{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/642f7ee8c7800c00115e9b2d?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Friday, April 7, 2023","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/show-cover.png?height=200","description":"<p>The Centers for Medicare and Medicaid Services issued its final 2024 rule for Medicare Advantage and Medicare Part D.&nbsp;The Food and Drug Administration seeks more clarity from drug manufacturers amid drug shortages. And, a second state places health insurer Friday Health Plans under supervision. That’s coming up on today’s episode of Gist Healthcare Daily.</p><p><br></p>","author_name":"Gist Healthcare Daily"}